leadf
logo-loader
viewCanntab Therapeutics Ltd

Buds & Duds: Cannabis stocks climb; Canntab shares soar on hemp-cultivation licence

Buds of the day are Canntab Therapeutics Ltd (CSE:PILL.CN) (OTCMKTS:CTABF), PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF). The duds are The Supreme Cannabis Company Inc (TSE:FIRE) (OTCMKTS:SPRWF), BlissCo Cannabis Corp (CSE:BLIS). 

Quick facts: Canntab Therapeutics Ltd

Price: 0.74 CAD

CSE:PILL
Market: CSE
Market Cap: $23.29 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Canntab Therapeutics achieves major milestone receiving first U.S. patent...

Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CEO Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has secured protection for their intellectual property receiving a U.S. patent for “Modified Release Multi-Layer Tablet Cannabinoid Formulations.” Latowsky...

1 week, 1 day ago

2 min read